Next Article in Journal
Metabolism-Disrupting Chemicals Affecting the Liver: Screening, Testing, and Molecular Pathway Identification
Next Article in Special Issue
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma
Previous Article in Journal
PTCHD1 Binds Cholesterol but Not Sonic Hedgehog, Suggesting a Distinct Cellular Function
Previous Article in Special Issue
Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
 
 
Review

Article Versions Notes

Int. J. Mol. Sci. 2023, 24(3), 2685; https://doi.org/10.3390/ijms24032685
Action Date Notes Link
article xml file uploaded 31 January 2023 08:49 CET Original file -
article xml uploaded. 31 January 2023 08:49 CET Update https://www.mdpi.com/1422-0067/24/3/2685/xml
article pdf uploaded. 31 January 2023 08:50 CET Version of Record https://www.mdpi.com/1422-0067/24/3/2685/pdf
article html file updated 31 January 2023 08:51 CET Original file -
article html file updated 1 March 2023 11:51 CET Update -
article html file updated 8 March 2023 20:36 CET Update https://www.mdpi.com/1422-0067/24/3/2685/html
Back to TopTop